Short-term Effects of Oxytocin Nasal Spray on Chronic Tinnitus
- Registration Number
- NCT02508220
- Lead Sponsor
- Berthold Langguth, MD, Ph.D.
- Brief Summary
The study compares the short-term tinnitus reduction following a single oxytocin intervention with a placebo control condition.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- chronic tinnitus with a duration > 6 months
- medical examination by an ENT specialist
- sufficient knowledge of the Portuguese language to follow the instructions and answer the questionnaires
- VAS score >4 points
Exclusion Criteria
- vascular tinnitus
- muscular tinnitus
- conductive hearing loss
- previous experience with oxytocin nasal spray
- additional medications during the intervention
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Arm && Interventions
Group Intervention Description Oxy-Placebo Placebo Syntocinon first, Placebo second 2 puffs in each nostril Placebo-Oxy Syntocinon Placebo first, Syntocinon second 2 puffs in each nostril Placebo-Oxy Placebo Placebo first, Syntocinon second 2 puffs in each nostril Oxy-Placebo Syntocinon Syntocinon first, Placebo second 2 puffs in each nostril
- Primary Outcome Measures
Name Time Method Change of Clinical global impression scale 30 minutes after intervention Change of tinnitus on VAS 30 minutes after intervention
- Secondary Outcome Measures
Name Time Method Tinnitus Matching within one hour before intervention Frequency measured in Hz
Minimum Masking Level measured in dB HL within one hour before intervention measured in dB HL
Audiometry measured in dB HL within one hour before intervention measured in dB HL